It is challenging to reliably assess the motor features of Parkinson's disease in real‐time.
This has motivated the search for new digital outcomes that can objectively and remotely …

Parkinson's disease (PD) is a global health challenge, yet historically studies of PD have
taken place predominantly in European populations. Recent genetics research conducted in …

The discovery of a pathogenic variant in the alpha-synuclein (SNCA) gene in the Contursi
kindred in 1997 indisputably confirmed a genetic cause in a subset of Parkinson's disease …

Abstract Device-aided therapies (DAT), which include deep brain stimulation and pump-
based continuous dopaminergic stimulation with either levodopa or apomorphine, are …

Fermented food has unique properties and high nutritional value, and thus, should constitute
a basic element of a balanced and health-promoting diet. However, it can accumulate …

Background: Parkinson's disease (PD) is a complex neurodegenerative disorder impacting
everyday function and quality of life. Rehabilitation plays a crucial role in improving …

Neurological disorders represent some of the most challenging therapeutic areas for
successful drug approvals. The escalating global burden of death and disability for such …

Background As a disease characterised by non-motor and very visible motor symptoms,
Parkinson's disease has been associated with multiple forms of stigma, while awareness …

The relationship between dopaminergic treatment and freezing of gait (FOG) in Parkinson's
disease (PD) is complex: levodopa is the most effective symptomatic treatment for FOG, but …

Background Parkinson's disease (PD) is a rapidly growing neurodegenerative disorder, but
up‐to‐date epidemiological data are lacking in Latin America. We sought to estimate the …